News and Announcements
GlaxoSmithKline Extends Service Agreement with MedAdvisor
- Published June 16, 2016 2:19PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
16th June 2016, ASX Announcement
Highlights
- GlaxoSmithKline (GSK) Australia extends its services agreement with MedAdvisor for a further 12 months.
- GSK will continue utilising MedAdvisor’s medication management platform to provide relevant information for patients prescribed three medicines within GSK Australia’s respiratory portfolio.
- Agreement will generate Patient Engagement Program (PEP), formerly knows as Medication Training and Adherence Campaigns (MTAC), revenue for MedAdvisor.
- Allows GKS Australia to leverage the MedAdvisor platform to support patients on the safe and effective use of these medicines.
MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that the Australian arm of leading global pharmaceutical company, GlaxoSmithKline Australia Pty (GSK) has extended its services agreement with MedAdvisor for a further 12 months.
Under the agreement, GSK Australia will continue providing tailored messages to patients prescribed medicines with GSK Australia’s respiratory portfolio.
To view the full announcement, please click on the button below.
Company Updates
The Yield Illusion: Inside RAM’s Strategy to Withstand the Credit Shakeout
As interest rates reprice in 2026, the rush into private credit has created a dangerous trap for yield-hungry investors. Real Asset Management Group CEO Scott Kelly exposes the “yield illusion” dominating the market and explains why an origination-led, low-arrears mortgage strategy is the ultimate defense against an impending credit shakeout.
Office sector ‘unloved’ no more: Acure’s $80m Brisbane bet
While institutional investors remain wary of the office sector, Acure Asset Management is doubling down. Founder Angelo Del Borrello explains the “unloved” asset strategy behind his latest $80 million Brisbane acquisition and why the 2032 Olympics are creating a unique arbitrage opportunity for private syndicates.
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
Backed By Leading Investment Groups and Family Offices
